Back to Agenda
PANEL DISCUSSION: LOOKING BACK AT THE 10 YEARS OF THE PAEDIATRIC LEGISLATION - THE WAYS FORWARD
Session Chair(s)
Emilie Desfontaine
Operational Investor
Jeito Capital, France
Andrea Ecker
Scientific Officer, Paediatric Medicines Office
European Medicines Agency, Netherlands
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Speaker(s)
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Florian Schmidt, JD, LLM
DG SANTE, European Commission, Belgium
Deputy Head of Unit B5 – Medicines: Policy, Authorisation and Monitoring
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Dirk Mentzer, DrMed, MD
Paul-Ehrlich-Institut, Germany
PDCO Chair 2013-2019; Head of Pharmacovigilance Unit
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Paolo Tomasi, MD, PhD
European Medicines Agency, Netherlands
Head of Paediatric Medicines
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Martine Dehlinger-Kremer, PhD
ICON Plc, Germany
Vice President Scientific Affairs, Pediatric Subject Matter Expert
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Mark Turner, MD, PhD, MRCP, FFPM
University of Liverpool, United Kingdom
Chief Executive Officer of the c4c- Stichting (c4c-S) & Professor of Neonatology
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Kerry Leeson-Beevers
Alström Syndrome UK, United Kingdom
National Development Manager
Have an account?